DALLAS Kimberly-Clark Corp. reported a 5.6% drop to $4.7 billion in its second-quarter net sales this year, while overall sales volumes faded 2%.
The company's K-C professional and consumer tissue businesses felt the adverse affects of the current economy as the company's global healthcare business sales surged 14%.
Diluted net income per share for the quarter was 97 cents, compared with 99 cents per share in 2008.
"Business conditions remained challenging in the second quarter, as the economic environment and weak foreign currency rates continued to impact our results. All-in-all, we made progress in a number of areas and expect to build on this performance with improved bottom-line results in the second half of the year," said chairman and CEO Thomas J. Falk.